drugset / Trial / NCT00078468

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

NCT00078468 ↗

Phase 2 Completed 56 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the response rate in patients with metastatic colorectal cancer who failed treatment with a 5-Fluorouracil/Leucovorin regimen and up to one other chemotherapeutic regimen (not including adjuvant chemotherapy).

Timeline

Start
2003-12
Primary completion
—
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PELITREXOL Small molecule — —

Indications